Treace Medical Concepts Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +52.6% | -17.8% | -13.0% | +1.4% | +52.4% | -23.5% | -9.9% | +6.0% | +24.5% | -24.5% | -3.9% | – | |
| – | +43.4% | -11.7% | -13.3% | +2.0% | +47.8% | -19.3% | -9.8% | +9.1% | +15.3% | -19.2% | -0.2% | – | |
| – | +54.9% | -19.2% | -12.9% | +1.3% | +53.5% | -24.5% | -9.9% | +5.2% | +26.9% | -25.8% | -4.8% | – | |
| – | -4.6% | +26.7% | -1.9% | -3.8% | +5.0% | +6.8% | -1.2% | -14.9% | -2.9% | +1.8% | -5.3% | – | |
| – | +6.0% | +6.8% | -1.0% | -4.9% | +0.6% | +16.0% | +2.2% | +0.8% | -10.8% | +11.4% | -5.7% | – | |
| – | +13.7% | +4.2% | -4.8% | -10.1% | +8.6% | +3.2% | -4.8% | +1.2% | +1.7% | -3.1% | -7.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.6% | +1.0% | -0.4% | +0.1% | +0.1% | -0.2% | +0.8% | +1.3% | +0.9% | +16.3% | -0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +266.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -498.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.